Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6,768,178
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
411,122
-
Shares change
-
+119,194
-
Total reported value, excl. options
-
$2,609,970
-
Value change
-
+$756,512
-
Number of buys
-
8
-
Number of sells
-
-1
-
Price
-
$6.34
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q2 2020
15 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q2 2020.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 411,122 shares
of 6,768,178 outstanding shares and own 6.07% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (214,091 shares), MEITAV DASH INVESTMENTS LTD (85,904 shares), GOLDMAN SACHS GROUP INC (27,312 shares), HighTower Advisors, LLC (22,224 shares), IPG Investment Advisors LLC (22,200 shares), RENAISSANCE TECHNOLOGIES LLC (17,100 shares), GEODE CAPITAL MANAGEMENT, LLC (15,145 shares), UBS Group AG (2,860 shares), SIGNATUREFD, LLC (1,462 shares), and Tower Research Capital LLC (TRC) (1,372 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.